1 Canadian Stock Down 42% to Buy and Hold Forever

This health tech stock is trading at a discount as it continues to grow and expand a business very much in demand.

Key Points
  • Well Health Technologies Corp. (TSX:WELL) is digitizing Canada's healthcare system with the country's largest outpatient clinic network and technology solutions.
  • The company raised 2026 guidance to $1.58-$1.65 billion in revenue and $185-$195 million in adjusted EBITDA following its latest quarter.
  • Despite being down 42% from recent highs and trading below $5, the stock remains a strong long-term buy as the company continues expanding its in-demand healthcare digitization platform.

There are plenty of Canadian stocks that continue to perform well on the TSX. In this article, I’d like to discuss one that has not been performing so well, despite a strong thesis for the underlying business.

Well Health Technologies Corp. (TSX: WELL) has been hard at work digitizing the Canadian healthcare industry. It’s a transformation that’s been sorely needed, and one that’s creating tons of value for doctors and patients alike. So why is Well Health Technologies’ stock price still stuck below $5?

telehealth stocks

Image source: Getty Images

What is this Canadian stock all about?

Well Health is an omnichannel digital healthcare company that has the largest outpatient medical clinic network in Canada. This network consists of primary, specialized, and diagnostic healthcare services and facilities. These facilities use Well Health’s technology solutions to enhance productivity, profitability and patient care.

But Well Health’s offering doesn’t stop there. Even healthcare providers who don’t choose to join Well Health’s clinic network can still purchase its technology solutions. These solutions include electronic medical records (EMR) platforms and services, digital booking, and e-referrals.

In short, Well Health Technologies is modernizing and digitizing the Canadian healthcare system, and the rapid growth of the company is evidence that this is very much in demand.

Well Health financials

This Canadian stock has been rapidly growing for quite a few years now. In fact, the company has had a fantastic five years – consistent double-digit revenue growth and increasing profitability and cash flows. Revenue increased more than 360% to $1.4 billion in 2025. Also, adjusted earnings per share (EPS) was $0.50, up from a mere $0.05 in 2021.

Also, Well Health’s latest quarterly results came in strong once again. Although revenue growth was slower, at 12%, the company closed two acquisitions in the quarter, which will help increase future growth rates. In fact, the business continues to compound and the company was seeing a return of stronger momentum in the back end of the second quarter.

A key takeaway from the quarter is the company raised its revenue and earnings guidance once again. The new 2026 revenue guidance is now between $1.58 billion to $1.65 billion. And the new 2026 adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) guidance is now between $185 million and $195 million.  

A Canadian stock to hold forever

While the recent quarter posted record patient visits and strong additions to its clinic network, the earnings results were not as impressive. In fact, earnings per share (EPS) came in at $0.04, down from $0.10 in the same period last year. This was due to higher interest expense and acquisition costs.

Digitizing the Canadian healthcare system takes time and investment. This is a long process, but Well Health continues to grow and expand as its offering is very much in demand. Looking ahead, I expect Well Health to continue to drive profitability and revenue. While the stock is down 42% from its recent highs, it’s still a strong long-term buy, in my view.

Fool contributor Karen Thomas has positions in Well Health Technologies. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

More on Tech Stocks

space ship model takes off
Tech Stocks

Ottawa’s Defence Spending Boom: This Canadian Tech Stock is Already Cashing In

MDA has identifiable government and defence work, but its backlog and profit margins reveal more than the spending headlines.

Read more »

Printing canadian dollar bills on a print machine
Tech Stocks

I’d Keep Shopify for its 18% Free Cash Flow Margin

With an expanding 18% free cash flow margin and massive share buybacks, Shopify proves why it remains a top TSX…

Read more »

quantum computing is still in infancy
Tech Stocks

A Quantum Computing Stock Canadian Investors Can Buy Now

Looking for a quantum computing stock? D-Wave offers exposure to an emerging industry, with paying customers and plenty still to…

Read more »

ETF is short for exchange traded fund, a popular investment choice for Canadians
Tech Stocks

A Handful of Tech Giants Is Carrying Wall Street: Canadians Holding U.S. Index ETFs Should Know How Concentrated They Really Are

XQQ's top 10 holdings make up 46% of the fund. See how concentrated Canada's Nasdaq 100 ETF is and why…

Read more »

man makes the timeout gesture with his hands
Dividend Stocks

Why Dividend Cuts Happen and How to Spot the Warning Signs

Learn why dividend cuts happen and how to spot warning signs, using BCE and TELUS to examine cash flow, debt,…

Read more »

The letters AI glowing on a circuit board processor.
Tech Stocks

Nvidia Just Hit $5.8 Trillion: The Canadian Stock Riding the Same AI Wave

Celestica’s AI exposure is supported by operating results, while cash investment and valuation make the buying decision more demanding.

Read more »

man in bowtie poses with abacus
Tech Stocks

A Simple Way to Estimate Your Retirement Number

Here's how Canadian couples can calculate their retirement number in 2026.

Read more »

Thrilled women riding roller coaster at amusement park, enjoying fun outdoor activity.
Tech Stocks

Celestica Stock Has Been a Roller Coaster: What I’d Do With It Now

Despite near-term volatility risks, Celestica’s strong growth prospects could make it an attractive long-term investment for risk-tolerant investors.

Read more »